Updates in the Management of Cryptogenic Stroke and Patent Foramen Ovale

被引:5
作者
Stone, David K. [1 ]
Buchwald, Natalie [2 ]
Wilson, Christina A. [2 ]
机构
[1] First Phys Grp Sarasota Mem Hlth Care Syst, Sarasota, FL USA
[2] Univ Florida, Dept Neurol, Gainesville, FL USA
关键词
ACUTE ISCHEMIC-STROKE; MEDICAL THERAPY; RECURRENT STROKE; CLOSURE; PREVENTION; METAANALYSIS; CLASSIFICATION; WARFARIN; ASPIRIN;
D O I
10.1097/WNO.0000000000000896
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Stroke is a common neurological disorder and may present with visual symptoms. A thorough workup is warranted to determine the underlying cause of stroke to optimize secondary prevention. Despite a full workup, a high-risk mechanism may not be identified. Optimal treatment in this patient population has been the subject of recent research, particularly with regard to low-risk stroke mechanisms such as patent foramen ovale (PFO). Evidence acquisition: Using PubMed and published stroke guidelines, an evidence-based literature review was performed. Results: In this review, we compare cryptogenic stroke with the newer concept of embolic stroke of undetermined source, summarize the most common causes presumed to underlie these strokes, and review the evidence for optimal antithrombotic management. We also review recent clinical trials demonstrating a benefit for percutaneous closure of PFO for secondary stroke prevention in select patients. Conclusions: Stroke management is based on evaluation of individual patient-risk factors. Evaluation and treatment is ideally directed by a vascular neurologist to ensure optimal secondary prevention, especially in cases where an underlying etiology is not identified on initial workup.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 35 条
[1]   Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials [J].
Abo-salem, Elsayed ;
Chaitman, Bernard ;
Helmy, Tarek ;
Boakye, Eric Adjei ;
Alkhawam, Hassan ;
Lim, Michael .
JOURNAL OF NEUROLOGY, 2018, 265 (03) :578-585
[2]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[3]   New Approach to Stroke Subtyping: The A-S-C-O (Phenotypic) Classification of Stroke [J].
Amarenco, P. ;
Bogousslavsky, J. ;
Caplan, L. R. ;
Donnan, G. A. ;
Hennerici, M. G. .
CEREBROVASCULAR DISEASES, 2009, 27 (05) :502-508
[4]   Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke [J].
Carroll, John D. ;
Saver, Jeffrey L. ;
Thaler, David E. ;
Smalling, Richard W. ;
Berry, Scott ;
MacDonald, Lee A. ;
Marks, David S. ;
Tirschwell, David L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (12) :1092-1100
[5]   Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials [J].
Darmoch, Fahed ;
Al-Khadra, Yasser ;
Soud, Mohamad ;
Fanari, Zaher ;
Alraies, M. Chadi .
CEREBROVASCULAR DISEASES, 2018, 45 (3-4) :162-169
[6]   Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source [J].
Diener, H. -C. ;
Sacco, R. L. ;
Easton, J. D. ;
Granger, C. B. ;
Bernstein, R. A. ;
Uchiyama, S. ;
Kreuzer, J. ;
Cronin, L. ;
Cotton, D. ;
Grauer, C. ;
Brueckmann, M. ;
Chernyatina, M. ;
Donnan, G. ;
Ferro, J. M. ;
Grand, M. ;
Kallmuenzer, B. ;
Krupinski, J. ;
Lee, B. -C. ;
Lemmens, R. ;
Masjuan, J. ;
Odinak, M. ;
Saver, J. L. ;
Schellinger, P. D. ;
Toni, D. ;
Toyoda, K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) :1906-1917
[7]   Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale [J].
Furlan, Anthony J. ;
Reisman, Mark ;
Massaro, Joseph ;
Mauri, Laura ;
Adams, Harold ;
Albers, Gregory W. ;
Felberg, Robert ;
Herrmann, Howard ;
Kar, Saibal ;
Landzberg, Michael ;
Raizner, Albert ;
Wechsler, Lawrence .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (11) :991-999
[8]   Recurrent Stroke Reduction with Patent Foramen Ovale Closure versus Medical Therapy Based on Patent Foramen Ovale Characteristics: A Meta-Analysis of Randomized Controlled Trials [J].
Garg, Aakash ;
Thawabi, Mohammed ;
Rout, Amit ;
Sossou, Chris ;
Cohen, Marc ;
Kostis, John B. .
CARDIOLOGY, 2019, 144 (1-2) :40-49
[9]  
Giblett Joel P, 2019, Interv Cardiol, V14, P34, DOI 10.15420/icr.2018.33.2
[10]   Atrial Fibrillation in Patients with Cryptogenic Stroke [J].
Gladstone, David J. ;
Spring, Melanie ;
Dorian, Paul ;
Panzov, Val ;
Thorpe, Kevin E. ;
Hall, Judith ;
Vaid, Haris ;
O'Donnell, Martin ;
Laupacis, Andreas ;
Cote, Robert ;
Sharma, Mukul ;
Blakely, John A. ;
Shuaib, Ashfaq ;
Hachinski, Vladimir ;
Coutts, Shelagh B. ;
Sahlas, Demetrios J. ;
Teal, Phil ;
Yip, Samuel ;
Spence, J. David ;
Buck, Brian ;
Verreault, Steve ;
Casaubon, Leanne K. ;
Penn, Andrew ;
Selchen, Daniel ;
Jin, Albert ;
Howse, David ;
Mehdiratta, Manu ;
Boyle, Karl ;
Aviv, Richard ;
Kapral, Moira K. ;
Mamdani, Muhammad .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26) :2467-2477